Bio-IT World Expo Bound for Europe and Biotechnica



By Bio-IT World staff

April 7, 2009 | For seven years, Bio-IT World has hosted an annual conference and expo in the United States. This fall, it will make its long-awaited debut in Europe in conjunction with Biotechnica 2009.

The initiative is the result of a new partnership between Bio-IT World’s parent organization, Cambridge Healthtech Institute (CHI), and Deutsche Messe, to organize and host two major life science conferences at Biotechnica 2009, which takes place in Hannover, Germany, October 6-8, 2009. The other conference being held is the Protein Engineering Summit (PEGS) Europe.

“We are thrilled to have the opportunity to finally bring the Bio-IT World Conference to Europe, and especially to partner with such a prestigious event as Biotechnica,” said Dr Kevin Davies, Editor-in-Chief of Bio-IT World magazine. “Across the continent, European researchers, pharma companies and start-ups are advancing new ideas and technologies that are driving basic research and drug development. We are truly excited to provide a new forum to bring this talent together.”

CHI and Bio-IT World have been exploring ways to bring the conference onto European soil, while still retaining the flagship Bio-IT event in Boston each spring. The co-location with Biotechnica provides a superb opportunity to host the event in the midst of a well-known trade fair.  The organizers hope that the presence of hundreds of cutting-edge exhibitors and first-rate conference tracks will make for a superb event.

Phillips Kuhl, President and founder of CHI, said: “We have always felt that it was important to the success of CHI to have a stronger European presence, in addition to attracting a number of European exhibitors and attendees to the events that we hold in the U.S.  This collaboration with Biotechnica allows us to be more aggressive in growing within Europe, with very good synergy between what our conferences and Biotechnica provide to help support each other.” 

With the rapid growth in high throughput data generation, from genomics and biomarkers on the biological side to faster high throughput screening and high content imaging, IT and informatics has become increasingly crucial for improving research productivity.  Bio-IT World Europe 2009 will feature four tracks in all: one will explore IT infrastructure solutions in hardware and software.  The concurrent track will include talks on bioinformatics for genomics, data integration and knowledge management.

Additional details, including instructions for submitting proposals to speak at the conference, can be found at: www.bio-itworldexpo.com/europe

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi whp 2
Managing the Modern Genomics Data Flood
Sponsored by SGI

Managing and storing the perfect storm of multi-disciplined data pouring from next generation sequencers and other omics instruments is a central challenge in life sciences. Discover in this paper how the SGI ArcFiniti storage solution, optimized for unstructured genomics and life sciences data can: 

  • Reduce costs, proactively protect data integrity, and deliver the high performance I/O required for genomics data processing and analysis.  
  • Effectively manage capacities from 156TB to 1.4PB as a disk based, integrated hardware and software platform 


sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .